Lumasiran sodium | m-entrepreneurship.com

Product Name :
Lumasiran sodium

Search keywords :
Lumasiran (sodium)

drugId :
null

Target Vo:
Hydroxyacid oxidase 1

Target Vo Short Name :
HAO1

Moa_Name:
RNA interference

First Approval Country :
EU

First Approval Date Filter:
2020

Origin Company_Name :
Alnylam Pharmaceuticals Inc

Active Company_Name :
Alnylam Netherlands Bv

Active Indication_Name:
Hyperoxaluria, Primary

In Active Indication_Name:
Kidney Calculi

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Brentuximab In Vitro
Phospho-Akt1(Ser473) Rabbit mAb Autophagy
Hes1 Antibody: Hes1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 30 kDa, targeting to Hes1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts